Status:
COMPLETED
Omega 3 Fatty Acids in Patients With Chronic Renal Disease
Lead Sponsor:
University of Chile
Collaborating Sponsors:
Servicio de Salud Metropolitano Oriente
Conditions:
Renal Insufficiency, Chronic
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
To study the tolerance and efficacy of an omega 3 fatty acids supplement on renal and vascular function and inflammatory parameters in patients with chronic renal disease
Detailed Description
In a double blind trial in patients with chronic renal disease, the effects of a 3.7 g supplement of docosahexanoic and eicosapentanoic acids or a supplement of a similar dose of corn oil during 12 we...
Eligibility Criteria
Inclusion
- Urinary albumin excretion over 30 mg/g creatinin
- Chronic renal failure stage 2 to 4
- Absence of serious conditions such as cáncer, decompensated heart failure, chronic infections and severe arterial lesions
Exclusion
- Blood glucose levels over 180 mg/dl or glycosilated hemoglobin over 8%
- Presence of cognitive impairment that does not allow to sigin a written informed consent
- Alcohol or illicit drug abuse
Key Trial Info
Start Date :
September 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03280615
Start Date
September 20 2017
End Date
October 31 2018
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Nutrition and Food Technology University of Chile
Santiago, Santiago Metropolitan, Chile